Search Results - "MINUTOLO, Filippo"
-
1
Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy
Published in Journal of hematology and oncology (20-06-2018)“…Bcr-Abl inhibitors paved the way of targeted therapy epoch. Imatinib was the first tyrosine kinase inhibitor to be discovered with high specificity for Bcr-Abl…”
Get full text
Journal Article -
2
Activators of Sirtuin-1 and their Involvement in Cardioprotection
Published in Current medicinal chemistry (01-01-2018)“…SIRT1 is a nicotinamide adenosine dinucleotide (NAD+)-dependent deacetylase, which removes acetyl groups from many target proteins, such as histone proteins,…”
Get more information
Journal Article -
3
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies
Published in Cell metabolism (04-12-2018)“…The microenvironment influences cancer drug response and sustains resistance to therapies targeting receptor-tyrosine kinases. However, if and how the tumor…”
Get full text
Journal Article -
4
An update on therapeutic opportunities offered by cancer glycolytic metabolism
Published in Bioorganic & medicinal chemistry letters (01-11-2014)“…[Display omitted] Almost all invasive cancers, regardless of tissue origin, are characterized by specific modifications of their cellular energy metabolism. In…”
Get full text
Journal Article -
5
The Benzoylpiperidine Fragment as a Privileged Structure in Medicinal Chemistry: A Comprehensive Review
Published in Molecules (Basel, Switzerland) (01-05-2024)“…The phenyl(piperidin-4-yl)methanone fragment (here referred to as the benzoylpiperidine fragment) is a privileged structure in the development of new drugs…”
Get full text
Journal Article -
6
Structural Optimization of 4‑Chlorobenzoylpiperidine Derivatives for the Development of Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors
Published in Journal of medicinal chemistry (23-11-2016)“…Monoacylglycerol lipase (MAGL) inhibitors are considered potential therapeutic agents for a variety of pathological conditions, including several types of…”
Get full text
Journal Article -
7
Lactate dehydrogenase-A inhibition induces human glioblastoma multiforme stem cell differentiation and death
Published in Scientific reports (23-10-2015)“…Therapies that target the signal transduction and metabolic pathways of cancer stem cells (CSCs) are innovative strategies to effectively reduce the recurrence…”
Get full text
Journal Article -
8
Sirtuin 1-Activating Compounds: Discovery of a Class of Thiazole-Based Derivatives
Published in Molecules (Basel, Switzerland) (01-10-2022)“…Sirtuin 1 (SIRT1) is a NAD+-dependent deacetylase implicated in various biological and pathological processes, including cancer, diabetes, and cardiovascular…”
Get full text
Journal Article -
9
SMS121, a new inhibitor of CD36, impairs fatty acid uptake and viability of acute myeloid leukemia
Published in Scientific reports (20-04-2024)“…Acute myeloid leukemia (AML) is the most common form of acute leukemia in adults and the second most common among children. AML is characterized by aberrant…”
Get full text
Journal Article -
10
Metabolic Effects of New Glucose Transporter (GLUT-1) and Lactate Dehydrogenase-A (LDH-A) Inhibitors against Chemoresistant Malignant Mesothelioma
Published in International journal of molecular sciences (24-04-2023)“…Malignant mesothelioma (MM) is a highly aggressive and resistant tumor. The prognostic role of key effectors of glycolytic metabolism in MM prompted our…”
Get full text
Journal Article -
11
Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance
Published in Haematologica (Roma) (01-04-2021)Get full text
Journal Article -
12
Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds
Published in British journal of cancer (18-08-2020)“…Background Expression of proton-coupled folate transporter (PCFT) is associated with survival of mesothelioma patients treated with pemetrexed, and is reduced…”
Get full text
Journal Article -
13
Discovery of N-Hydroxyindole-Based Inhibitors of Human Lactate Dehydrogenase Isoform A (LDH-A) as Starvation Agents against Cancer Cells
Published in Journal of medicinal chemistry (24-03-2011)“…Highly invasive tumor cells are characterized by a metabolic switch, known as the Warburg effect, from “normal” oxidative phosphorylation to increased…”
Get full text
Journal Article -
14
Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
Published in Journal of enzyme inhibition and medicinal chemistry (01-01-2019)“…Monoacylglycerol lipase (MAGL) is an attractive therapeutic target for many pathologies, including neurodegenerative diseases, cancer as well as chronic pain…”
Get full text
Journal Article -
15
Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against Cancer
Published in Journal of agricultural and food chemistry (19-07-2017)“…Inhibition of lactate dehydrogenase (LDH) represents an innovative approach to tackle cancer because this peculiar glycolytic metabolism is characteristic of…”
Get full text
Journal Article -
16
New PIN1 inhibitors identified through a pharmacophore-driven, hierarchical consensus docking strategy
Published in Journal of enzyme inhibition and medicinal chemistry (01-12-2022)“…PIN1 is considered as a therapeutic target for a wide variety of tumours. However, most of known inhibitors are devoid of cellular activity despite their good…”
Get full text
Journal Article -
17
Three-Dimensional Analysis of the Interactions between hLDH5 and Its Inhibitors
Published in Molecules (Basel, Switzerland) (13-12-2017)“…Inhibitors of human lactate dehydrogenase ( LDH5)-the enzyme responsible for the conversion of pyruvate to lactate coupled with oxidation of NADH to NAD⁺-are…”
Get full text
Journal Article -
18
Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer
Published in Journal of hematology and oncology (06-01-2017)“…There is increasing evidence of a constitutive activation of Akt in pancreatic ductal adenocarcinoma (PDAC), associated with poor prognosis and…”
Get full text
Journal Article -
19
Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study
Published in Molecules (Basel, Switzerland) (26-12-2020)“…Monoacylglycerol lipase (MAGL) is an important enzyme of the endocannabinoid system that catalyzes the degradation of the major endocannabinoid…”
Get full text
Journal Article -
20
Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors
Published in Journal of enzyme inhibition and medicinal chemistry (01-01-2018)“…Fyn tyrosine kinase inhibitors are considered potential therapeutic agents for a variety of human cancers. Furthermore, the involvement of Fyn kinase in…”
Get full text
Journal Article